Deregulated nuclear factor jB (NF-jB) activation plays an important role in inflammation and tumorigenesis. ABIN proteins have been characterized as negative regulators of NF-jB signaling. However, their mechanism of NF-jB inhibition remained unclear. With the help of a yeast two-hybrid screen, we identified ABIN proteins as novel ubiquitin-interacting proteins. The minimal ubiquitin-binding domain (UBD) corresponds to the ABIN homology domain 2 (AHD2) and is highly conserved in ABIN-1, ABIN-2 and ABIN-3. Moreover, this region is also present in NF-jB essential modulator/IjB kinase c (NEMO/IKKc) and the NEMO-like protein optineurin, and is therefore termed UBD in ABIN proteins and NEMO (UBAN). Nuclear magnetic resonance studies of the UBAN domain identify it as a novel type of UBD, with the binding surface on ubiquitin being significantly different from the binding surface of other UBDs. ABIN-1 specifically binds ubiquitinated NEMO via a bipartite interaction involving its UBAN and NEMO-binding domain. Mutations in the UBAN domain led to a loss of ubiquitin binding and impaired the NF-jB inhibitory potential of ABINs. Taken together, these data illustrate an important role for ubiquitin binding in the negative regulation of NF-jB signaling by ABINs and identify UBAN as a novel UBD.
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The nuclear factor-kB (NF-kB) family of transcription factors plays a fundamental role in inflammatory and immune responses as well as tumorigenesis. Understanding the molecular mechanisms that regulate NF-kB activation is therefore of crucial importance for the development of novel therapeutic approaches (Calzado et al., 2007) . Over the last few years, a growing number of proteins in the NF-kB pathway were reported to be modified with ubiquitin, to interact with ubiquitin or to interact with the ubiquitination machinery. Especially, K63-linked polyubiquitin turned out to play an important role as a signaling factor (Wullaert et al., 2006) . Among the ubiquitinated proteins in the NF-kB pathway is the serine/threonine kinase receptor-interacting protein 1 (RIP1). Upon stimulation of cells with tumor necrosis factor (TNF) and recruitment of RIP1 to the TNF-receptor complex, RIP1 becomes polyubiquitinated. The K63-linked polyubiquitin chains attached to RIP1 were recently discovered to mediate RIP1 binding to NF-kB essential modulator (NEMO) (Ea et al., 2006; Wu et al., 2006) , which is the regulatory subunit of the IkB kinase (IKK) complex. NEMO itself was also reported to be ubiquitinated upon different stimuli including TNF and overexpression of the API2/MALT1 fusion protein that is characteristic for certain MALT lymphomas. The functional relevance of the NEMO ubiquitination, however, is still under debate and may also depend on the stimulus (Tang et al., 2003; Zhou et al., 2004 Zhou et al., , 2005 Shambharkar et al., 2007) .
The ABIN proteins were originally identified as three different intracellular NF-kB inhibitory proteins that bind the deubiquitinating protein A20 (Heyninck et al., 1999; Van Huffel et al., 2001; Wullaert et al., 2007) . ABINs show partial sequence homology in a number of short regions, designated ABIN homology domains (AHDs). AHD1 mediates A20 binding, whereas AHD2 is essential for their NF-kB inhibitory potential. However, the exact mechanism of NF-kB inhibition by ABINs remains unclear.
ABIN proteins bind to ubiquitin
To identify novel ubiquitin-interacting proteins, we performed a yeast two-hybrid screening with ubiquitin as bait. Sequences encoding ABIN-3, NEMO and optineurin were obtained. Alignment of these sequences revealed that all three proteins share a highly conserved stretch of around 40 amino acids that were previously described as AHD2 (Heyninck et al., 2003) or NEMOlike motif (NLM) (Agou et al., 2004) . The identified motif is also present in ABIN-1 and ABIN-2. Therefore, we speculated that this motif might be responsible for binding to ubiquitin, not only in NEMO and optineurin as reported recently (Ea et al., 2006; Wu et al., 2006; Zhu et al., 2007) , but also in ABIN-1, ABIN-2, ABIN-3, and called it UBAN (UBD in ABIN proteins and NEMO) domain (Figure 1a ). To verify this assumption, we used GST-monoUb and GST-tetraUb to pull down ABIN-1, ABIN-2 and ABIN-3 proteins that were expressed in HEK293T cells. For all ABIN proteins, we observed binding to ubiquitin. Mutations in the highly conserved DFxxER motif of ABIN-1, ABIN-2 and ABIN-3 reduced the binding to ubiquitin significantly ( Figure 1b ).
To identify a structural basis and to estimate K d of the UBAN-Ub interaction, we measured chemical shift perturbations (Ds) observed in the ubiquitin nuclear magnetic resonance spectra upon titration of ABIN-1 459À545 . The representative region of ubiquitin spectra recorded in the presence of varied ABIN-1 459À545 
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S Wagner et al concentration is presented in Figure 2a . In addition to the Ds, we have observed a strong line-broadening effect (see L8, I13, L71, R72 and L73 resonances in Figure 2a ). The same results could be achieved with different ubiquitin and UBAN constructs (Supplementary Figure 1A ). Ds analysis based on a simple monomolecular binding model revealed K d values in the range of 100 mM (Supplementary Figure 1B) , which
Novel UBD in ABIN proteins S Wagner et al is comparable to the affinities of other UBD-Ub interactions (Hicke et al., 2005) . The analysis of sequential distribution of Ds in ubiquitin is shown in Figure 2b . The most affected ubiquitin residues are located in the areas of b1-b2 and the C-terminal b5.
Additionally, residues forming a hydrophobic spot and located in the C-terminal area of a1 and b3-b4 (near I44) show moderate Ds. Being mapped on the ubiquitin molecule, all these residues form a well-pronounced surface (Figure 2c) , which covers the ubiquitin molecule on one side. Interestingly, the UBAN-binding surface on ubiquitin differs from the binding surface of other UBDs. It is larger and mainly includes the areas of b1-b2 and Cterminal b5, while the I44 patch, which is part of most UBD-Ub interactions, shows only a minor involvement. The disruptive effect of the UBAN ER/AA and DF/NA mutations on the UBAN-Ub interaction was also monitored by nuclear magnetic resonance titration experiments. The degree of interaction was estimated by line broadening of specific ubiquitin signals in the spectra (Figure 2d ). Individual differences in certain chemical shift perturbations (Figure 2e ) and higher (2-4 times) (Heyninck et al., 2003) . The latter region overlaps with the NEMO-binding domain (NBD, aa 513-601) (Mauro et al., 2006) . Therefore, we investigated whether the disruption of the NBD also abrogates the NF-kB inhibitory effect of ABIN-1. In contrast to ABIN-1 ER/AA, ABIN-1 DNBD (D560-590) still inhibited TNF-induced NF-kB activation, but significantly less efficient compared to wild-type ABIN-1 (Figure 3c ; left panel). This reduced NF-kB inhibitory potential was not due to reduced ubiquitin binding since the deletion of NBD did not affect the binding of ABIN-1 to GSTtetraUb (Figure 3c ; right panel). Taken together, these data indicate that the UBAN-mediated binding of ABIN-1 to ubiquitin as well as its NBD-mediated binding to NEMO is involved in its NF-kB inhibitory function.
ABIN-1 interacts with ubiquitinated NEMO
The above-mentioned findings suggest that ABINs exert their NF-kB inhibitory function by binding to ubiquitinated NF-kB signaling proteins. We have already pointed out that ABIN proteins interfere with NF-kB signaling downstream of TRAF2/6, but upstream of IKKb (Heyninck et al., 1999; Van Huffel et al., 2001; Wullaert et al., 2007) , and others showed that ABIN proteins can bind NEMO (Liu et al., 2004; Mauro et al., 2006; Weaver et al., 2007) . Moreover, we here showed that both the UBAN domain and the NBD of ABIN-1 are involved in its NF-kB inhibitory function ( Figure 3c ). NEMO is known to be polyubiquitinated in response to different stimuli including TNF or overexpression of the API2/MALT1 fusion protein involved in MALT lymphoma (Tang et al., 2003; Zhou et al., 2004 ; Figure 4a ). Moreover, ABIN-1 overexpression not only inhibits TNF-induced NF-kB activation, but also API2/MALT1-induced NF-kB activation (Figure 4b ). Therefore, we hypothesized that NEMO ubiquitination would enhance its recognition and binding by ABIN-1. To investigate this further, we studied the effect of API2/MALT1 overexpression on the binding of polyubiquitinated NEMO with the MAD and UBAN domains of ABIN-1, respectively. Interestingly, GST-MAD and GST-UBAN were able to pull down polyubiquitinated NEMO, whereas the ubiquitinbinding deficient GST-UBAN DF/NA mutant was not (Figure 4c, lanes 6-8) . Moreover, consistent with the increased polyubiquitination of NEMO in response to API2/MALT1 overexpression (Figure 4a ), the latter also increased the amount of ubiquitinated NEMO that binds GST-MAD and GST-UBAN (Figure 4c , lanes 10-12). Furthermore, binding of polyubiquitinated NEMO was more pronounced in the case of GST-MAD, which also contains the NBD domain of ABIN-1, compared to GST-UBAN (Figure 4c , lanes 6 and 10 versus lanes 7 and 11). This allows us to conclude that ABIN-1 binds polyubiquitinated NEMO via a bipartite interaction involving its UBAN and NBD domains. Involvement of the NBD as a direct binding surface guarantees that ABIN-1 specifically recognizes polyubiquitinated NEMO. Indeed, GST-MAD was not able to bind polyubiquitinated RIP1, whereas GST-NEMO could (Figure 4d ), demonstrating the specificity of the interaction of ABIN-1 with polyubiquitinated NEMO. Consistent with our observations, ABIN-1 has recently been shown to physically link A20 to NEMO and to facilitate A20-mediated deubiquitination of NEMO (Mauro et al., 2006 The NBD of ABIN-1 contributes to the NF-kB inhibition by ABIN-1. Cells were transfected with 10 ng ABIN-1 wild type, ER/AA, DNBD or ER/AA DNBD and analyzed in an NF-kB-dependent luciferase reporter gene assay (left panel). HEK293T cells were transfected with the indicated E-tagged ABIN-1 expression constructs and lysates were used for pull-down assays with GST and GST-tetraUb, followed by western blot analysis with anti-E-tag antibodies (right panel). All results are representative of three independent experiments.
Novel UBD in ABIN proteins S Wagner et al Figure 4 The UBAN domain of ABIN-1 mediates its interaction with polyubiquitinated NEMO. (a) API2/MALT1 induces NEMO polyubiquitination. HEK293T cells were transfected with 0.5 mg FLAG-NEMO, 0.5 mg HA-ubiquitin and with or without 1 mg API2/ MALT1. Cell extracts were immunoprecipitated with FLAG antibodies, followed by western blot analysis with anti-HA antibodies to reveal ubiquitinated NEMO. Total NEMO and API2/MALT1 expression was revealed by western blot analysis with anti-FLAG-HRP and anti-MALT on total cell extracts. (b) ABIN-1 inhibits API2/MALT1-induced NF-kB activation. HEK293T cells were transfected with 20 ng API2/MALT1 with or without 10 ng ABIN-1 wild-type or ER/AA mutant. The next day, cell lysates were analyzed for NF-kB-dependent luciferase expression (upper panel) and cell supernatants were analyzed for the presence of NF-kB-dependent cytokine IL-8 (lower panel). (c) Polyubiquitinated NEMO interacts with the MAD and UBAN domains of ABIN-1. HEK293T cells were transfected as described in panel a. Each cell extract was divided over four setups and subjected to an in vitro GST pull-down assay with the indicated GST proteins (GST, GST-UBAN, GST-UBAN DF/NA or GST-MAD), followed by Coomassie blue staining (second panel from top) or western blot analysis with anti-HA antibodies to detect the binding of ubiquitinated NEMO (upper panel) . Total NEMO and API2/MALT1 expression was revealed by western blot analysis of total cell lysates with anti-FLAG-HRP and anti-MALT1, respectively (lower panels). (d) The ABIN-1 MAD does not bind to ubiquitinated RIP1 upon TNF stimulation. HeLa S3 cells were stimulated for 3 min with 20 ng ml À1 TNF or left untreated. Cell lysates were used for GST pull-down assays with the indicated GST proteins, followed by Coomassie blue staining (middle panel) or western blot analysis with anti-RIP1 to detect the binding of ubiquitinated RIP1 (upper panel). Total RIP1 expression was revealed by western blot analysis of total cell lysates with anti-RIP1 (lower panel). All results are representative of three independent experiments.
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